Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07620535 · ClinicalTrials.gov registry record
Decision Counseling and Follow-up for Shield+ Patients
A clinical trial, sponsored by Guardant Health.
- Not yet
- Registry status
- 350
- Enrollment target
NCT07620535: Clinical Trial study, sponsored by Guardant Health.
NCT07620535 is a clinical trial that has not yet begun recruiting, run by Guardant Health. The registered enrollment target is 350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07620535 has not yet begun recruiting, sponsored by Guardant Health.
- NOT YET RECRUITING
- Registry status
- 350 participants
- Enrollment target
Study Summary
Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.
Primary Outcome
Determine the level of preference for, decisional conflict related to, intention to have CDE following a Shield+ result at baseline and after decision counseling and assess change.
Interventions
- BEHAVIORAL Decision Counseling Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-06 |
What is known before NCT07620535 opens enrollment
NCT07620535 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Decision Counseling Session is the first listed.
NCT07620535 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07620535 about?
NCT07620535 is a clinical study titled "Decision Counseling and Follow-up for Shield+ Patients". Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.
What is the current status of trial NCT07620535?
This trial is currently not yet recruiting. The enrollment target is 350 participants. The study started on 2026-06. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07620535?
The interventions under investigation include: Decision Counseling Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT07620535?
This trial is sponsored by Guardant Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia